Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients

NCT00123643 is registered in ClinicalTrials.gov with St. Paul Heart Clinic as lead sponsor.

NCT NCT00123643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients
Lead sponsor
St. Paul Heart Clinic
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2003
Completion date
December 31, 2005
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus